Evaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control
Clinical trial NCT02273050 · COMPLETED
Trial details
- NCT number
- NCT02273050
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-08-01
- Enrollment
- 1136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.